These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6835002)

  • 1. The effect of tripelennamine alone and in combination with opiates to produce antinociception in mice.
    Hui FW; Sun CJ; Tocus EC; Hanig JP
    Life Sci; 1983 Apr; 32(14):1531-8. PubMed ID: 6835002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate mixed agonist-antagonist interactions with histamine antagonists vs. morphine.
    Hui FW; Sun CL; Hanig JP
    Neurobehav Toxicol Teratol; 1985; 7(5):443-7. PubMed ID: 4080063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Apr; 229(1):214-7. PubMed ID: 6707938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic potentiation and the distribution of morphine in the presence of triplennamine in mice.
    Bluhm RE; Evans MA; Zsigmond EK
    Life Sci; 1983; 33 Suppl 1():673-6. PubMed ID: 6664243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of H1 blockers alone and in combination with morphine to produce antinociception in mice.
    Sun CL; Hui FW; Hanig JP
    Neuropharmacology; 1985 Jan; 24(1):1-4. PubMed ID: 2858829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of pentazocine antinociception by tripelennamine in the rat.
    Yeh SY
    J Pharmacol Exp Ther; 1985 Dec; 235(3):683-9. PubMed ID: 4078730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihistaminic-opioid combination: effect on locomotor activity in mice.
    Sansone M
    Pol J Pharmacol Pharm; 1988; 40(5):515-23. PubMed ID: 3253717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate dependence alters central reward of nalbuphine or pentazocine plus tripelennamine.
    Huston-Lyons D; Bain GT; Kornetsky C
    Eur J Pharmacol; 1989 Oct; 169(1):153-7. PubMed ID: 2599009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of cholinergic transmission at the spinal level to opiate effectiveness.
    Dirksen R; Nijhuis GM
    Eur J Pharmacol; 1983 Jul; 91(2-3):215-21. PubMed ID: 6617742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous measurement of opiate-induced histamine release in the periaqueductal gray and opiate antinociception: an in vivo microdialysis study.
    Barke KE; Hough LB
    J Pharmacol Exp Ther; 1993 Aug; 266(2):934-42. PubMed ID: 7689107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of nalbuphine anti-analgesia in the rat.
    Khasar SG; Gear RW; Levine JD
    Neurosci Lett; 2003 Jul; 345(3):165-8. PubMed ID: 12842282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H1- and H2-histamine receptor blockers and opiate analgesia in mice.
    Leza JC; Lizasoain I; Lorenzo P
    Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):671-8. PubMed ID: 1983158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate in mice.
    Welch SP; Dewey WL
    J Pharmacol Exp Ther; 1986 Nov; 239(2):320-6. PubMed ID: 3095536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
    Welch SP; Dunlow LD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):390-9. PubMed ID: 8229767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nalbuphine, pentazocine, and butorphanol interactions with tripelennamine in mice.
    Schmidt WK; Marynowski ME; Smith C
    NIDA Res Monogr; 1986; 67():145-6. PubMed ID: 3092060
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenosine and opiate-like substances mediates antinociception at the spinal cord.
    Yang SW; Chen JY; Zhang ZH; Xie YF; Qiao JT; Dafny N
    Brain Res; 1995 Feb; 673(1):170-4. PubMed ID: 7757473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents.
    Ossipov MH; Suarez LJ; Spaulding TC
    Anesth Analg; 1989 Mar; 68(3):194-200. PubMed ID: 2537587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of catalepsy induced by narcotic agents during Haffner's test for analgesia.
    Beecham IJ; Handley SL
    Psychopharmacologia; 1974; 40(2):157-64. PubMed ID: 4476084
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of nalbuphine alone and in combination with tripelennamine on rewarding brain stimulation thresholds in the rat.
    Unterwald EM; Kornetsky C
    Pharmacol Biochem Behav; 1986 Sep; 25(3):629-32. PubMed ID: 3774829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen.
    Yaksh TL; Reddy SV
    Anesthesiology; 1981 Jun; 54(6):451-67. PubMed ID: 6112935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.